Plain-English translation of NCT05143970 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a Phase 1 research study testing a new medication called IPH5301, which works by blocking a protein (CD73) that helps cancers hide from the immune system. Researchers want to find the right dose and learn whether this medication can help fight advanced cancers โ either used alone or combined with other standard cancer treatments like chemotherapy and a drug called trastuzumab.
Current treatments don't work for everyone with advanced cancer, and some patients run out of options. This medication targets a new mechanism to help the body's immune system recognize and fight cancer cells more effectively.
The study has two phases. In the first phase, patients receive increasing doses of the medication alone to find the safest and most effective dose. In the second phase, patients with HER2-positive breast cancer receive the medication combined with two standard cancer drugs (chemotherapy and trastuzumab). You would have multiple clinic visits for blood tests, imaging scans, heart monitoring, and possibly a tumor biopsy to see how the treatment is working.
AI-generated summary from trial data ยท Jun 25, 2026 ยท Not medical advice
France